Inventage Lab인벤티지랩
389470 · KOSDAQ · ₩389470 · 인벤티지랩
Valuation model · Discounted cash flow (DCF)
We use a 5-year discounted cash flow: the value of the cash the business is expected to produce, in today's money.
Fair value per share
₩2,060
vs the current price (₩23,950)
- Enterprise value
- −₩27B
- Equity value
- ₩27B
- WACC
- 7.4%
Model estimate based on the assumptions shown. Not a price target and not a buy or sell signal. This is not financial advice.
Why the model and the price differ
The model is 91% away from today's price. A gap this size usually means the market expects something the past figures don't show yet, or the model leaves something out. What we can see:
- No operating margin up to 90% gets the model to today's price at these growth assumptions.
- Margins ranged from −2,425.1% to −292.8% over the last 4 years, so this is a cyclical business. The model uses the average; the price may be set by where the cycle is now. Try the margin fade option.
- In the projection, spending on equipment, software and working capital takes most or all of the after-tax operating profit, so free cash flow is thin. Companies that invest heavily often look like this until spending slows.
Treat the model as a starting point: change the assumptions to the story you believe, and compare with the multiples check below.
Bear / Base / Bull
- Bear
- ₩2,491
- −89.6%
- Base
- ₩2,060
- −91.4%
- Bull
- ₩1,422
- −94.1%
Bear: revenue growth 3 points lower every year, EBIT margin 2 points lower, WACC 1 point higher. Bull: the opposite.
Assumptions
Sign in to change the assumptions and see the results update. Sign in
Cycle options
Margin path
Every year uses the cycle-average margin (−20.0%).
Revenue growth
- -7.6%
How much sales grow that year, compared with the year before.
Default: the last 3 years' revenue growth (-7.6% a year, annual reports), fading to 3% by year 5.
- -4.9%
How much sales grow that year, compared with the year before.
Default: the last 3 years' revenue growth (-7.6% a year, annual reports), fading to 3% by year 5.
- -2.3%
How much sales grow that year, compared with the year before.
Default: the last 3 years' revenue growth (-7.6% a year, annual reports), fading to 3% by year 5.
- 0.4%
How much sales grow that year, compared with the year before.
Default: the last 3 years' revenue growth (-7.6% a year, annual reports), fading to 3% by year 5.
- 3%
How much sales grow that year, compared with the year before.
Default: the last 3 years' revenue growth (-7.6% a year, annual reports), fading to 3% by year 5.
Business
- -20%
Operating profit as a share of revenue.
Default: through-the-cycle average of the last 12 months and the last 4 annual reports' operating margins.
- 27.5%
Share of operating profit paid as corporate tax.
Default: Korea's top corporate tax rate (25%) plus 10% local income tax.
- 414.8%
The non-cash cost of wearing out equipment, added back to cash flow (% of revenue).
Default: not in the statements, so 80% of capital spending (most spending replaces equipment that wears out).
- 518.5%
Money spent on factories, equipment, software and other long-term assets (% of revenue).
Default: average of the last 3 annual reports (cash flow statements; equipment and intangibles).
- -10%
Stock and unpaid customer bills, less unpaid supplier bills, as a % of revenue. Each year's extra revenue ties up this much more cash.
Default: working capital (current assets less cash and deposits, minus current liabilities other than borrowings) as a share of revenue, averaged over the last 3 years.
Discount rate
- 2%
How fast cash flows keep growing every year after year 5.
Default: about Korea's long-run inflation plus real growth.
- 4.11%
Yield on Korea's 10-year government bond: the return with almost no risk.
Default: Korea Treasury Bond 10-year yield on 2026-10-28.
- 0.6
How much the share moves when the market moves: 1 means just like the market.
Default: 105 weeks of weekly returns against KOSPI (official index); raw beta 0.32, adjusted toward 1 and kept between 0.6 and 2.0.
- 5.5%
The extra return investors want for owning shares instead of bonds.
Default: a typical premium for Korean shares.
- 5.61%
The interest rate the company would pay to borrow.
Default: the 10-year yield plus a 1.5% credit spread.
Starting point
- Revenue (TTM to H1 2026)
- ₩2.5B
- Net debt (borrowings and leases − cash and deposits)
- −₩77B
- − Minority interests
- ₩23B
- Shares
- 13,307,708
- Share price
- ₩23,950
- Market cap
- ₩319B
TTM = trailing 12 months: the last four reported quarters added together. "TTM to H1 2026" is the 12 months up to the latest quarterly or half-year report (H1 = to the end of June). Year 1 grows from there.
Past years and projection
Grey columns are reported results from the annual reports (after-tax EBIT at the model's tax rate), so you can check the growth and margin assumptions against the past. Years 1–5 are the model.
| FY2023 | FY2024 | FY2025 | Year 1 | Year 2 | Year 3 | Year 4 | Year 5 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | ₩658M | ₩1.8B | ₩2.9B | ₩2.3B | ₩2.2B | ₩2.1B | ₩2.1B | ₩2.2B |
| Growth | −82.3% | 170.9% | 64.8% | −7.6% | −4.9% | −2.3% | 0.4% | 3.0% |
| EBIT | −₩16B | −₩19B | −₩28B | −₩457M | −₩435M | −₩425M | −₩426M | −₩439M |
| EBIT margin | −2,425.1% | −1,063.6% | −965.7% | −20.0% | −20.0% | −20.0% | −20.0% | −20.0% |
| After-tax EBIT | −₩12B | −₩14B | −₩21B | −₩331M | −₩315M | −₩308M | −₩309M | −₩318M |
| + Depreciation | — | — | — | ₩9.5B | ₩9B | ₩8.8B | ₩8.8B | ₩9.1B |
| − Capital spending | ₩7.1B | ₩4.2B | ₩6.9B | ₩12B | ₩11B | ₩11B | ₩11B | ₩11B |
| − Working capital | −₩28B | ₩20B | ₩18B | ₩19M | ₩11M | ₩5M | −₩849,168 | −₩6.4M |
| Free cash flow | — | — | — | −₩2.7B | −₩2.6B | −₩2.5B | −₩2.5B | −₩2.6B |
| Discount factor | — | — | — | 0.931 | 0.867 | 0.807 | 0.751 | 0.700 |
| Present value | — | — | — | −₩2.5B | −₩2.2B | −₩2B | −₩1.9B | −₩1.8B |
Terminal value −₩23B, worth −₩16B today: 61% of enterprise value. It assumes spending settles at 110% of depreciation once growth slows to the terminal rate.
Cross-check: what the market has paid before
For cyclical businesses, analysts check a DCF against the multiples the stock has traded at through past cycles. Price / book is the usual anchor for them: P/E looks highest at the bottom of a cycle, when earnings are smallest, and lowest at the top. The price each band would give today:
| Low | Typical | High | |
|---|---|---|---|
| Price / book (book value ₩6,640 a share)Now 3.61× | ₩28,3504.27× | ₩89,78413.5× | ₩230,29734.7× |
Low, typical and high are the 10th percentile, middle and 90th percentile of month-end multiples since 2023, each against the latest report out by then, per share at today's share count; loss years and P/E above 100 are left out. Run-rate earnings are one quarter × 4, not a forecast. Model estimate based on the assumptions shown. Not a price target and not a buy or sell signal.
Sensitivity
Fair value per share as two inputs change; the middle is the current case.
| WACC ↓ · Terminal growth → | 1.0% | 1.5% | 2.0% | 2.5% | 3.0% |
|---|---|---|---|---|---|
| 6.4% | ₩1,991 | ₩1,857 | ₩1,692 | ₩1,485 | ₩1,218 |
| 6.9% | ₩2,135 | ₩2,026 | ₩1,894 | ₩1,733 | ₩1,530 |
| 7.4% | ₩2,258 | ₩2,167 | ₩2,060 | ₩1,931 | ₩1,773 |
| 7.9% | ₩2,363 | ₩2,287 | ₩2,199 | ₩2,094 | ₩1,967 |
| 8.4% | ₩2,455 | ₩2,391 | ₩2,316 | ₩2,229 | ₩2,126 |
Now (TTM)
- Market cap
- ₩319B
- Enterprise value
- ₩236B
- P/E
- —
- P/B
- 3.6×
- P/S
- 128.9×
- EV/EBITDA
- —
- Dividend yield
- 0.0%
Over time (at each year end)
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Price | ₩84,200 | ₩21,300 | ₩17,400 | ₩9,780 |
| Market cap | ₩1.1T | ₩283B | ₩232B | ₩130B |
| P/E | — | — | — | — |
| P/B | 17.4× | 8.7× | 52.5× | 4.3× |
| P/S | 381.3× | 159.0× | 351.8× | 35.0× |
| EV/EBITDA | — | — | — | — |
| Dividend yield | 0.0% | — | — | — |
Versus similar companies
| Company | P/E | P/B | P/S | EV/EBITDA | Dividend yield |
|---|---|---|---|---|---|
| Inventage Lab | — | 3.6× | 128.9× | — | 0.0% |
| Samsung Biologics | 32.0× | 7.6× | 14.0× | — | 0.0% |
| Celltrion | 27.9× | 2.5× | 9.0× | — | 0.0% |
| Alteogen | 80.5× | 29.0× | 61.2× | — | 0.1% |
| SK biopharmaceuticals | 14.7× | 5.8× | 6.8× | — | 0.0% |
| Yuhan | 24.0× | 2.4× | 2.5× | 31.3× | 0.8% |
| HLB | — | 15.7× | 55.6× | — | 0.0% |
| Similar companies (median) | 27.9× | 6.7× | 11.5× | 31.3× | 0.0% |
Calculated from end-of-day prices and filed financial statements. Not a recommendation. This is not financial advice.
Also known as: Inventage Lab / 인벤티지랩 / 389470 / KRX:389470
Source: KRX statistical information